Investigation of a retrospective in-hospital database on surveying complications of patients with lifestyle-related diseases and their treatment

Investigation of a retrospective in-hospital database on surveying complications of patients with lifestyle-related diseases and their treatment - Investigation of a retrospective in-hospital database on surveying complications of patients with lifestyle-related diseases and their treatment

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044064

Enrollment

8000

Registered

2021-04-28

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lifestyle-related diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients visiting our hospital who are considered to be included in the comprehensive consent. Those who have an ID at the hospital during the entire period from the opening of the hospital to the present.

Exclusion criteria

Exclusion criteria: Those who do not agree with the comprehensive consent Others who are judged to be inappropriate by the investigator

Design outcomes

Primary

Measure	Time frame
Period of the following events from the start of observation Nephropathy Retinopathy Neuropathy Macroangiopathy: ischemic heart disease (myocardial infarction, angina, cardiovascular reconstruction, etc.) Cerebrovascular accident (stroke, transient ischemic attack, etc.) Heart failure, ASO, amputation of lower limbs. Malignant tumor Infection	—

Secondary

Measure	Time frame
Search for factors related to the primary endpoint. For diabetic patients, we will stratify insulin-introduced patients according to the duration of illness and glycemic control status, and examine the effect on the onset of the primary endpoint.	—

Countries

Japan

Contacts

Public ContactAkifumi Kushiyama

Meiji Pharmaceutical University Dept. Pharmacotherapy

kushiyama@my-pharm.ac.jp0424958725

Outcome results